
Weight Management
Injection + Glycine · NAD+ · B-12 · L-Carnitine
Tirzepatide is the most advanced GLP-1 weight loss therapy available — acting on both GLP-1 and GIP receptors for dual appetite suppression and metabolic regulation. This formulation adds Glycine to support gut health and improve tolerability, alongside NAD+ and B-12 for enhanced metabolic function. Clinical trials demonstrate an average of ~20% total body weight loss.
Glycine is a metabolic amino acid that supports gut lining integrity, reduces inflammation, and may help ease GI side effects common with GLP-1 therapy.
Clinician review required. Prescription issued by board-certified provider.
No hidden fees. No surprises. Cancel anytime.
Your dose is increased gradually to minimize side effects and maximize results. Your clinician adjusts your protocol based on your individual response.
From intake to treatment in as little as 24 hours.
Answer a short HIPAA-secure questionnaire about your health history, weight goals, and any medications.
A board-certified provider reviews your intake and, if appropriate, prescribes compounded tirzepatide with a personalized dosing schedule.
Your injectable tirzepatide + Glycine formula is shipped from a licensed 503A compounding pharmacy, temperature-controlled and discreet.
Your provider monitors your progress, adjusts doses as needed, and supports you every step of the way.
The most powerful GLP-1 therapy available — enhanced with Glycine for better tolerability.
Month-to-month · Cancel anytime · Clinician review required · Rx by board-certified provider
What You Need to Know
Tirzepatide with glycine is a once-weekly injectable medication that combines a dual GLP-1/GIP receptor agonist with the amino acid glycine. Tirzepatide reduces appetite and improves blood sugar control, while glycine may support collagen production, sleep quality, and insulin sensitivity. It is prescribed by licensed clinicians and prepared by state-licensed compounding pharmacies.
Side by Side
Both are GLP-1 weight-loss medications. Here's how they compare so you can choose with your clinician.
| Compare | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | Dual GLP-1 + GIP agonist |
| Dosing | Weekly injection or daily sublingual | Once-weekly injection |
| Avg. Weight Loss | ~15% over 68 weeks | ~20–22% over 72 weeks |
| Starting Price | $239/mo (injection w/ B12) | $339/mo (injection w/ B12) |
| Best For | Steady, well-tolerated loss | Higher average loss, dual pathway |